Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 4826 - 4850 of 5568 in total

5-(4-CHLORO-5-PHENYL-3-THIENYL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE

Experimental

(3R,4R,5R)-5-(HYDROXYMETHYL)-1-(3-PHENYLPROPYL)PIPERIDINE-3,4-DIOL

Experimental

(3R,4S)-1-(3,4-DIMETHOXYPHENYL)-3-(3-METHYLPHENYL)PIPERIDIN-4-AMINE

Experimental

4-[3-(1,4-diazepan-1-ylcarbonyl)-4-fluorobenzyl]phthalazin-1(2H)-one

Experimental

6,7-DIMETHOXY-4-[(3R)-3-(2-NAPHTHYLOXY)PYRROLIDIN-1-YL]QUINAZOLINE

Experimental

4-{[(2R)-2-(2-methylphenyl)pyrrolidin-1-yl]carbonyl}benzene-1,3-diol

Experimental

Bacillus calmette-guerin substrain danish 1331 live antigen

BCG SSI has been used in trials studying Tuberculosis.
Investigational

Autologous adipose-derived stromal vascular fraction cells

Investigational

L-Pentahomoserine

Experimental

N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium

Calcium and magnesium salts used therapeutically in hepatobiliary dysfunction.
Experimental

TAS-106

TAS-106 is a new nucleoside antimetabolite. TAS-106 has demonstrated strong antitumor activity without serious toxicity in nude rat models bearing human tumours .
Investigational

Tomivosertib

Tomivosertib is under investigation in clinical trial NCT03318562 (A PD Study of Oral eFT508 in Subjects With Advanced TNBC and HCC).
Investigational

NSC-663284

NSC-663284 is a potent quinolinedione Cdc25 phosphatase inhibitor.
Investigational

Izaflortaucipir

Investigational

1-(3-fluoro-4-(7-(5-methyl-1H-imidazol-2-yl)-1-oxo-2,3-dihydro-1H-isoindo-1-4-yl)-phenyl)-3-(3-trifluoromethyl-phenyl)-urea

Investigational

ADH-1

Adherex's biotechnology compound, ADH-1, targets N-cadherin, a protein present on certain tumor cells and established tumor blood vessels. ADH-1 is currently in clinical development in a combination program with a range of chemotherapeutic agents to investigate the synergistic effects noted in our preclinical models. At the end of 2006, the...
Investigational

Gosogliptin

Gosogliptin has been used in trials studying the treatment of Renal Insufficiency, Chronic.
Investigational

KRN-5500

KRN-5500 is under investigation in clinical trial NCT00002923 (KRN5500 in Treating Patients With Metastatic Solid Tumors).
Investigational

Vorasidenib

Investigational

MG-S-2525

Investigational

5-Bromo-N[2-(Dimethylamino)Ethyl]-9-Aminoacridine-4-Carboxamide

Experimental

(3R)-3-{[(Benzyloxy)carbonyl]amino}-2-oxo-4-phenylbutane-1-diazonium

Experimental

Adenylate-3'-phosphate-[[2'-deoxy-uridine-5'-phosphate]-3'-phosphate]

Experimental

(9S,10S)-9-(S-glutathionyl)-10-hydroxy-9,10-dihydrophenanthrene

Experimental

1-(3,5-DICHLOROPHENYL)-5-METHYL-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID

Experimental
Displaying drugs 4826 - 4850 of 5568 in total